India has worlds second highest burden of disease for sickle cell anaemia. The prevalence rates reach roughly 1% with highest numbers recorded in Chhattisgarh, Madhya Pradesh, Gujarat and Maharashtra.
Thousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn.
Zoladex will no longer be available in Australia from November, as the ABC first reported, but some existing patients will still be able to access it for an additional six months.